Cathflo activase 2 MG vials
Ended Awarded
- Contract number
- SPE2DB25FHW19
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,342
Award facts
- Contract value 100% obligated
- $16,342.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on July 14, 2025, represents a $16,342.05 firm fixed-price purchase of Cathflo Activase 2 mg vials issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The award is not a set-aside contract and carries an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its Corporate Office location. Cathflo Activase is a thrombolytic agent used in medical settings to restore function to occluded central venous catheters, representing a critical pharmaceutical supply for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen Drug Corp provides pharmaceutical products to multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key vendor in the DLA's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DB25FHW19?
SPE2DB25FHW19 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FHW19 worth?
The government has obligated $16,342 on SPE2DB25FHW19.
Is contract SPE2DB25FHW19 an order under another contract?
Yes. SPE2DB25FHW19 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHW19 competed?
The extent of competition for SPE2DB25FHW19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award